CBD disrupts fear memory reconsolidation through CB1 receptors in specific prefrontal cortex regions in rats

CBD impaired the reconsolidation of fear memories in rats by activating CB1 receptors in the anterior cingulate and prelimbic cortex, reducing plasticity markers linked to memory restabilization.

Bayer, Hugo et al.·Neuropharmacology·2022·Moderate EvidenceAnimal StudyAnimal Study
RTHC-03699Animal StudyModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Systemic CBD reduced Zif268/Egr1 protein (a synaptic plasticity marker for reconsolidation) in the anterior cingulate and prelimbic cortex but not the infralimbic cortex. CBD injected directly into the anterior cingulate or prelimbic cortex also impaired reconsolidation, with CB1 receptor blockade in all three subregions preventing the effect.

Key Numbers

CBD reduced Zif268/Egr1 in the anterior cingulate and prelimbic cortex but not infralimbic cortex. CB1 blockade in all three subregions prevented CBD's reconsolidation-impairing effect.

How They Did This

Rats underwent contextual fear conditioning, then received systemic CBD or vehicle after memory retrieval. Brain tissue was analyzed for Zif268/Egr1 expression. Separate experiments used local CB1 receptor antagonist (AM251) pretreatment or direct CBD injection into specific prefrontal cortex subregions.

Why This Research Matters

Understanding exactly where and how CBD disrupts fear memory reconsolidation could inform development of targeted treatments for PTSD and other disorders involving persistent traumatic memories.

The Bigger Picture

This study adds anatomical precision to the growing understanding of how CBD affects fear memories, suggesting that the dorsal prefrontal cortex regions are key sites of action rather than the ventral regions typically associated with fear extinction.

What This Study Doesn't Tell Us

Animal model only. Contextual fear conditioning is a simplified model of trauma. Only male rats were used. Direct injection doses may not reflect physiological CBD concentrations.

Questions This Raises

  • ?Would CBD show similar regional specificity in humans?
  • ?Could targeted CBD delivery to prefrontal cortex improve outcomes for PTSD patients?
  • ?Why does the infralimbic cortex respond differently?

Trust & Context

Key Stat:
CBD reduced fear memory plasticity markers in 2 of 3 prefrontal regions
Evidence Grade:
Rigorous mechanistic animal study with multiple experimental approaches, but human translation uncertain.
Study Age:
Published in 2022.
Original Title:
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.
Published In:
Neuropharmacology, 205, 108913 (2022)
Database ID:
RTHC-03699

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is memory reconsolidation?

When a stored memory is recalled, it temporarily becomes unstable and must be restabilized (reconsolidated) to persist. Disrupting this process can weaken the memory, which is why it is of interest for treating conditions like PTSD.

Which brain regions did CBD affect?

CBD reduced plasticity markers in the anterior cingulate and prelimbic cortex (dorsal prefrontal regions) but not the infralimbic cortex (ventral prefrontal region), suggesting a specific anatomical pattern of action.

Read More on RethinkTHC

Cite This Study

RTHC-03699·https://rethinkthc.com/research/RTHC-03699

APA

Bayer, Hugo; Stern, Cristina A J; Troyner, Fernanda; Gazarini, Lucas; Guimarães, Francisco S; Bertoglio, Leandro J. (2022). Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.. Neuropharmacology, 205, 108913. https://doi.org/10.1016/j.neuropharm.2021.108913

MLA

Bayer, Hugo, et al. "Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.." Neuropharmacology, 2022. https://doi.org/10.1016/j.neuropharm.2021.108913

RethinkTHC

RethinkTHC Research Database. "Medial prefrontal cortex mechanisms of cannabidiol-induced a..." RTHC-03699. Retrieved from https://rethinkthc.com/research/bayer-2022-medial-prefrontal-cortex-mechanisms

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.